7
Participants
Start Date
October 29, 2019
Primary Completion Date
August 30, 2022
Study Completion Date
October 24, 2022
Fenfluramine Hydrochloride
Oral aqueous solution of fenfluramine hydrochloride buffered to pH 5 and provided in concentrations of 2.5 mg/mL. Manufactured by Andersonbrecon, Inc. on behalf of Zogenix International Limited.
New York Langone Health Comprehensive Epilespy Center, New York
NYU Langone Health
OTHER